Jim TateJim Tate has spent a lifetime at the intersection of systems and stories. In recent years, both have converged on one of the most consequential scientific and cultural revivals of our time: psychedelic medicine.Writing under the banner Chronicles of Kykeon, Tate brings something rare to the psychedelic therapy conversation with the eye of an investigator, the instincts of a storyteller, and the patience to follow the archives and court transcripts wherever they lead. His essays range from the shadow histories of LSD's underground distribution networks to the forgotten women of psychedelic chemistry, from the contested terrain of psychedelic-assisted therapy to the veterans carrying ibogaine across the border in search of relief no VA clinic can provide.His Substack, Chronicles of Kykeon (@kykeon23), publishes regularly on the legacy, culture, and emerging science of psychedelic substances, exploring subjects from Nixon's war on drugs to the political economy of psilocybin access to the spiritual fault lines running quietly through the modern therapy movement.Tate is also the co-founder of Psylencia, a collaborative multimedia platform dedicated to raising the quality of dialogue in the psychedelic ecosystem, and host of Inside the Revival, a podcast featuring clinicians, researchers, harm reduction specialists, pharmacists, PhDs, pastors, and military veterans, a deliberately wide tent.His summer 2026 titles include Elders at the Threshold, an evidence-first guide to psychedelic medicine for older adults and seniors, and The Little Book of Salvia Divinorum, a concise, accessible introduction to one of the most enigmatic psychedelic plants in the broader conversation about consciousness and healing.The name kykeon is a declaration of intent. In ancient Greece, kykeon was the ceremonial drink at the center of the Eleusinian Mysteries, possibly psychedelic, certainly transformative, and millennia older than any modern revival. Tate is tracing a thread that runs through human consciousness itself. Read More Read Less